December 2020: China Regulatory Update

China Drug Review and Approval Update

According to the Announcement of the State Drug Administration on Implementation of the “Administrative Measures for Drug Registration” (No. 46 of 2020), to promote the drafting and formulation of related supporting normative documents and technical guidelines, deployment in the State Drug Administration Next, the Center for Drug Evaluation has researched and formulated the “Administrative Measures for the Disclosure of Drug Review and Approval Information“. It is now promulgated and will take effect on June 1, 2021.

Leave a Reply